Evelyn Partners Investment Management LLP Grows Stock Holdings in Intuitive Surgical, Inc. $ISRG

Evelyn Partners Investment Management LLP lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.6% during the first quarter, HoldingsChannel.com reports. The firm owned 62,473 shares of the medical equipment provider’s stock after purchasing an additional 8,874 shares during the quarter. Evelyn Partners Investment Management LLP’s holdings in Intuitive Surgical were worth $28,799,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in ISRG. State Street Corp boosted its holdings in Intuitive Surgical by 1.0% in the fourth quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock worth $8,892,753,000 after acquiring an additional 162,264 shares in the last quarter. Capital World Investors grew its position in Intuitive Surgical by 1.7% during the 4th quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock valued at $4,449,491,000 after purchasing an additional 127,526 shares during the last quarter. Norges Bank purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $2,856,987,000. Invesco Ltd. increased its stake in Intuitive Surgical by 17.4% during the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock valued at $2,338,350,000 after purchasing an additional 611,268 shares in the last quarter. Finally, Wellington Management Group LLP raised its holdings in Intuitive Surgical by 9.4% in the fourth quarter. Wellington Management Group LLP now owns 3,445,880 shares of the medical equipment provider’s stock worth $1,951,609,000 after buying an additional 294,651 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 5.7%

Shares of NASDAQ ISRG opened at $356.83 on Tuesday. The firm’s 50-day moving average price is $405.22 and its 200-day moving average price is $457.57. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The company has a market cap of $126.06 billion, a PE ratio of 40.87, a PEG ratio of 2.44 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.81 earnings per share. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several analyst reports. Piper Sandler set a $357.44 target price on shares of Intuitive Surgical in a research note on Monday. Jefferies Financial Group reduced their price target on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research report on Wednesday, April 22nd. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. TD Cowen lowered their price objective on Intuitive Surgical from $585.00 to $520.00 and set a “buy” rating on the stock in a research report on Monday, July 13th. Finally, Raymond James Financial reiterated an “outperform” rating and set a $483.00 target price (down from $577.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Twenty-one equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $519.13.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 119 shares of the business’s stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director directly owned 120 shares in the company, valued at $55,620. The trade was a 49.79% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 6,669 shares of company stock worth $2,822,405. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.